Case Report: Mesenteric Gastrointestinal Stromal Tumor (EGIST)
- Authors
- Pesántez Brito, Ismael Francisco; Ord´óñez Velecela, María Soledad; Oyervide Soto, Juan Manuel; García Cayamcela, Ana Be´lén; Mendieta Bermeo, Edgar Gustavo
- Format
- Article
- Status
- publishedVersion
- Description
ABSTRACT Extragastrointestinal stromal tumors are rare mesenchymal neoplasms that can occur in the omentum and mesentery. Little is known about its prognosis and management, so it is important to consider this pathology in order to find an adequate multidisciplinary diagnosis and treatment. We present the clinical case of a patient of the third age of the city of Cuenca that presented a clinical picture of pain, abdominal distension, lack of elimination of gases and feces of 24h of evolution, the physical examination showed a distended abdomen, pain on palpation diffusely, increased hydro noise. He was surgically intervened where a tumor was found 80 cm from the mesoenterium-dependent ileocecal valve, approximately 7x6 cm that involved intestinal loops; Histopathology reported a CD 117 positive extra gastrointestinal stromal tumor; patient evolved favorably, walking began at 24 hours and liquid diet at 72 hours with good tolerance, medical discharge was decided on the fifth day after surgery. Start oncological treatment at 4 months after surgery with imatinib 400mg, currently a patient with favorable evolution without recurrence.
RESUMEN Los tumores del estroma extragastrointestinal son neoplasias mesenquimatosas raras que pueden presentarse en epiplón y mesenterio. Se presenta el caso clínico de un paciente cuencano de la tercera edad con cuadro clínico caracterizado por dolor, distensión abdominal, falta de eliminación de gases y heces de 24h de evolución, al examen físico se evidenció abdomen distendido, dolor a la palpación en forma difusa, ruidos hidroaéreos aumentados.Fue intervenido quirúrgicamente, encontrándose un tumor a 80 cm de la válvula ileocecal dependiente de mesenterio, de aproximadamente 7x6 cm que comprometía asas intestinales; histopatología reportó un tumor del estroma extra gastrointestinal CD 117 positivo; paciente evoluciono favorablemente, se inició deambulación a las 24 horas y dieta líquida a las 72 horas con buena tolerancia, alta médica al quinto día postquirúrgico. Inicio tratamiento oncológico a los 4 meses posteriores a la cirugía con Imatinib 400mg, actualmente paciente con evolución favorable sin recurrencia.
- Publication Year
- 2019
- Language
- spa
- Topic
- Repository
- Revista Universidad de Cuenca
- Rights
- openAccess
- License
- Derechos de autor 2019 info:eu-repo/semantics/openAccess